-
-
-
News
April 14, 2019,
Meet us at the IABCR breast cancer conference 15-18 April, Egmond aan Zee, The Net...

-
Development of an Image-Guided Orthotopic Xenograft Mouse Model of Endometrial Cancer with Controllable Estrogen Exposure. Gonda FJ Konings, Niina Saarinen, Bert Delvoux, Loes Kooreman, Pasi Koskimies, Camilla Krakstad, Kristine E. Fasmer, Ingfrid S. Haldorsen, Amina Zaffagnini, Merja R. Häkkinen, Seppo Auriola, Ludwig Dubois, Natasja Lieuwes, Frank Verhaegen, Lotte EJR Schyns, Roy FPM Kruitwagen, ENITEC Consortium, Sofia Xanthoulea and Andrea Romano. Int J Mol Sci. 2018 Aug 28;19(9). PMC free full text

Characterization of Tumor Growth Supported by Novel Dihydrotestosterone Releasing Implants in a Subcutaneous Prostate Cancer Xenograft Model.Johanna Örling, Minna Auranen, Jukka P Rissanen, Jussi M Halleen, Jenni Bernoulli,Tiina E Kähkönen. ScandLas annual meeting 2018. Visit Pharmatest Services Ltd website: Pharmatest poster at ScandLas meeting 2018

Importance of Tumor Microenvironment in the Preclinical Estrogen Receptor Positive Breast Cancer –Primary Tumor and Bone Metastasis Models. Visit Pharmatest Services Ltd website: Pharmatest minisymposium at AACR meeting 2017

Estrogen induces severe urinary tract defects –a strain dependent difference in nude vs NOG female mice. Visit Pharmatest Services Ltd website: Pharmatest presentation at ScandLas meeting 2017

Novel long term substance delivery method in preclinical osteoporosis studies. Rissanen JP, Ruohonen ST, Jukarainen H. Osteoporos Int. 2016 April; 27 (1) supplement.

Ethylene vinyl acetate (EVA) as a new drug carrier for 3D printed medical drug delivery devices. Genina N, Holländer J, Jukarainen H, Mäkilä E, Salonen J, Sandler N. Eur J Pharm Sci. 2015 Nov 3.

Drug implants, technology serving delivery. Jukarainen H, Strömberg C. Duodecim.2004;120(16):2008-14. Review.

Novel delivery systems in contraception. Lähteenmäki P, Jukarainen H. Br Med Bull. 2000 56(3):739-48. Review.


-
About Us
 
Products
 
Research Applications
 
Ordering
 
References
 
Contact Us
 
65022  | Copyright © 2019 PreclinApps Ltd   
Web dev. Webbinen.net